학술논문
Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study
Document Type
Article
Author
Source
In Lung Cancer April 2024 190
Subject
Language
ISSN
0169-5002